Literature DB >> 36119286

The knowledge and attitude towards prostate cancer and screening practices among males in Saudi Arabia.

Abdulrahman Musaad Alothman1, Alhanouf Fahad Altamimi2, Alanoud Waleed Alhenaki1, Nouf Mohammed Almansour3, Abdulrhman Khalid Alhusaini1, Fahad Alateeq4.   

Abstract

Background: Early-stage prostate cancer can be asymptomatic. The digital rectal exam (DRE) and the prostate specific antigen (PSA) test are usually used for prostate cancer screening. This study aims to assess knowledge and attitudes towards prostate cancer screening among males in Saudi Arabia. Materials and
Methods: A cross-sectional study was conducted on Saudi males above the age of 40. A self-reported questionnaire was distributed online.
Results: A total of 368 males completed the questionnaire. In the studied group, 64.5% had heard about prostate cancer through social media (46.7%), the internet (40.1%), or healthcare providers (18.6%). In addition, around 20.3% of the participants had heard about the PSA screening test. Moreover, 55.2% of participants had an inadequate level of knowledge about prostate cancer and the PSA test, while 53.1% had a negative attitude.
Conclusion: There was a poor level of knowledge and attitude towards screening for prostate cancer among males in Saudi Arabia. This could be due to the lack of education on the risks of prostate cancer by healthcare providers. Copyright:
© 2022 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Carcinoma; PSA; knowledge survey; prostate cancer

Year:  2022        PMID: 36119286      PMCID: PMC9480705          DOI: 10.4103/jfmpc.jfmpc_1802_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Prostate cancer is the abnormal growth of the prostate gland, which is a small accessory gland of the male reproductive system that is located at the base of the bladder in front of the rectum. The prostate usually weighs about 20 g and produces proteolytic enzymes in semen to facilitate fertilization.[12] Prostate cancer is characterized by both physical and psychological symptoms.[3] It is usually asymptomatic at its early stages and presents with symptoms similar to benign prostatic hyperplasia such as interrupted flow, frequency, nocturia, hematuria, and dysuria at advanced stages.[45] Metastatic prostate cancer may spread to bones and cause pain in the hips, spine, or ribs.[5] Prostate cancer is the second most common malignancy and the fifth leading cause of death in men globally. It is estimated to cause 358,989 deaths per year, about 3.8% of all cancer-related deaths in men.[67] The American Cancer Society report predicted approximately 174,650 new cases of prostate cancer and 31,620 deaths due to prostate cancer in the United States in 2019. Moreover, prostate cancer affects black men more frequently than white men, indicating a genetic predisposition to cancer.[7] Prostate cancer screening is typically done by digital rectal exam (DRE) and prostate specific antigen (PSA) testing. Screening practices for prostate cancer remain controversial due to concerns with overdiagnosis. Routine DRE screening in primary care, according to some evidence, may not have a major effect on mortality, because of the high number of false positives, which leads to unnecessary invasive diagnostic test that can cause discomfort, erectile dysfunction, and urine incontinence, in addition to prostate cancer overdiagnosis and overtreatment.[8] The European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a significant reduction in prostate cancer mortality with PSA screening.[9] On the other hand, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial showed no significant reduction in mortality with early prostate cancer screening.[910] The American Cancer Society recommends the disclosure of all benefits, risks, and potential concerns of prostate cancer screening to people at high risk.[11] In Saudi Arabia, 323 new cases of prostate cancer were reported in 2014, ranking as the fourth most common type of cancer among men. The population growth rate was 5.5 cases per 100,000 men. The Eastern region recorded the highest incidence rate of 12.6 per 100,000 men, while the incidence rate in the Riyadh province increased by 9.5 per 100,000 Saudi men. The mean age at diagnosis was 73 years.[12] This study aims to assess the awareness and attitude towards prostate cancer screening among males in Saudi Arabia.

Methodology

A cross-sectional study was conducted through an online questionnaire onSaudi Arabian males who are above 40 years old. Respondents who did not match the study’s inclusion criteria were not allowed to participate. Data was collected using a self-administered questionnaire to determine the level of awareness and attitude toward prostate cancer screening. It was disseminated at random throughout several social media channels. There were three sections to the questionnaire. The first component consisted of socio-demographic questions about the participants’ age, educational level, occupation, and personal and family history of prostate diseases. The second component assessed participants’ understanding of prostate cancer, including risk factors, protective factors, and screening tests. The participants’ attitudes about prostate cancer screening procedures were measured in the third section. The sample size was estimated, and 358 people were found to be eligible. The data was analyzed using the Statistical Package for Social Sciences Program, version 24 (IBM Corp., Armonk, NY, USA). Frequency and percentages were used to describe categorical variables. Participants who responded to more than 60% of questions correctly were categorized as having adequate or positive knowledge and attitude. Chi-square test was used to determine the association between the socio-demographic data and the level of knowledge and attitude. A P value less than or equal to 0.05 was considered statistically significant. The duration of the study started from January 2021 to May 2021. The study was approved by the Institutional Review Board of Imam Muhammad bin Saud Islamic University in Saudi Arabia. Informed consent was obtained from all participants. All data were kept confidential and only used for the purposes of this study.

Results

A total of 368 males completed the questionnaire, of whom the majority were between 50–59 years old (43.5%). Around 94% of participants were Saudi, and 98% were married. Three-quarters of the sample were from the Central region (75.9%), while the rest were distributed across other regions of Saudi Arabia. More than half of the participants (56.2%) had a university level of education and were still working (61.7%) [Table 1].
Table 1

Demographic characteristics of participants

CountPercentage
Age
 40-4916041.7
 50-5916743.5
 60-695113.3
 70-7941.0
 ≤8020.5
Nationality
 Saudi34593.8
 Non-Saudi236.3
Marital status
 Single30.9
 Married33898.0
 Divorced41.2
Residency
 Central region26275.9
 Northern region41.2
 Southern region277.8
 Eastern region195.5
 Western region339.6
Education
 Preparatory school61.7
 Intermediate school164.6
 Secondary school8223.8
 University19456.2
 Higher level4713.6
Occupation
 Worker21361.7
 Not working133.8
 Retired11934.5
Demographic characteristics of participants Most of the participants (86.7%) reported a personal history of prostate conditions such as prostatic enlargement (65.1%), and 13.3% reported a family history of prostate conditions of mainly prostatic enlargement (52.6%). Furthermore, 7.9% had a personal history of prostate cancer [Table 2].
Table 2

Personal and family history of prostate conditions

FrequencyPercentage
Have you or any of your family member had prostate conditions?
 Yes, I had29986.7
 Yes, my family member4613.3
 No00.0
Who is the affected family member?
 Brother613.0
 Father4087.0
What was the condition?
 Prostate enlargement2052.6
 Prostate inflammation1539.5
 Prostate cancer37.9
What was your condition?
 Prostate enlargement2865.1
 Prostate inflammation1534.9
 Prostate cancer00.0
Personal and family history of prostate conditions According to Figure 1, 64.5% of participants had heard about prostate cancer mainly through social media (46.7%), the internet (40.1%), and healthcare providers (18.6%).
Figure 1

Source of information about prostate cancer

Source of information about prostate cancer Age over 50 years (63.8%) and family history (45.8%) were the most well-known risk factors among the participants. In addition, few participants were aware of smoking (22.8%), multiple sexual partners (21.3%), and alcohol (14.7%). On the other hand, 85.9% of participants believed that physical activity is the main protective factor against prostate cancer, followed by a high intake of fruits and vegetables (63.9%), and a low-fat diet (44%) [Figures 2 and 3].
Figure 2

Risk factors of prostate cancer

Figure 3

Protective factors against prostate cancer

Risk factors of prostate cancer Protective factors against prostate cancer Less than a quarter of the participants (20.3%) had heard about the PSA screening test through social media (47.1%), healthcare providers (38.2%), the internet (26.5%), or family and friends (20.6%) [Table 3].
Table 3

Knowledge about PSA and source of knowledge

CountPercentage
Do you hear about PSA test
 Yes7020.3%
 No27579.7%
Knowledge source about PSA
 Friends/family member1420.6%
 Social media3247.1%
 Internet1826.5%
 Healthcare provider2638.2%
Knowledge about PSA and source of knowledge Moreover, 55.2% of the sample had an inadequate level of knowledge about both prostate cancer and the PSA test, and 53.1% had a negative attitude towards them. The majority of participants reported that they had never been told about the PSA test or its advantages by their physicians (87.8% and 93.6%, respectively). Only 43 participants (12.5%) had done the PSA test before [Table 4].
Table 4

Knowledge and attitudes toward prostate cancer and PSA test

CountPercentage
Level of knowledge
 Inadequate21255.2%
 Adequate17244.8%
Attitude
 Negative20453.1%
 Positive18046.9%
Have you ever been told by your doctor about PSA?
 Yes4212.2%
 No30387.8%
Have you ever been told by your doctor about advantage of PSA?
 Yes226.4%
 No32393.6%
Have you had PSA before?
 Yes4312.5%
 No30287.5%
Knowledge and attitudes toward prostate cancer and PSA test The participants’ nationality had a statistically significant effect on the knowledge level and attitudes towards prostate cancer and the PSA test in which Saudi participants had a higher level of knowledge and a more positive attitude compared to non-Saudis (P < 0.001). In contrast, the age, education level, and occupation status had no significant effect on both the level of knowledge and attitude (P ≥ 0.05) [Table 5].
Table 5

The relationship between demographic characteristics and level of knowledge and attitudes

Level of knowledgeAttitudes


InadequateAdequateNegativePositive




CountPercentageCountPercentageCountPercentageCountPercentage
Age
 40-498841.57241.98642.27441.1
 50-599444.37342.48541.78245.6
 60-692612.32514.53115.22011.1
 70-7931.410.610.531.7
 80 or older10.510.610.510.6
0.8930.585
Nationality
 Saudi Arabia17388.3172100.016587.8180100.0
 Non-Saudi2311.700.02312.200.0
<0.001*<0.001*
Marital status
 Single21.210.610.621.1
 Married17098.316897.716298.217697.8
 Divorced10.631.721.221.1
0.5110.877
Education
 Preparatory school31.731.721.242.2
 Intermediate school116.452.984.884.4
 Secondary school3620.84626.74124.84122.8
 University9957.29555.210060.69452.2
 Higher level2413.92313.4148.53318.3
0.4670.095
Occupation
 Worker10560.710862.810865.510558.3
 Not working84.652.953.084.4
 Retired6034.75934.35231.56737.2
0.6910.372
The relationship between demographic characteristics and level of knowledge and attitudes

Discussion

Prostate cancer is usually asymptomatic and commonly diagnosed in the geriatric population.[47] Most cases are found incidentally in clinical settings. The number of cases of clinically diagnosed prostate cancer is expected to rise with the vast development of healthcare and screening advances in Saudi Arabia.[4] Although early screening is known to affect treatment outcomes significantly, it requires high levels of awareness among the public and a positive attitude towards it.[1314] This study aimed to assess the level of knowledge and attitude towards prostate cancer and early screening among the male population living in Saudi Arabia. In this study, 64.5% of participants had heard about prostate cancer through mainly social media (46.7%) and the internet (40.1%). These findings are lower than a study by Benurugo et al.[15] (2020), that found that 80% of their participants had heard about prostate cancer primarily from healthcare providers (77%) and less commonly from social media (5%) and the internet (6%). Similarly, a study conducted in Ghana reported that 96.3% of participants had heard about prostate cancer before from healthcare providers predominantly (40.3%).[16] Nevertheless, our results were higher than a study by Gift et al.[17] (2020), that showed that only 33.5% of participants had heard about prostate cancer. The low levels of knowledge in this study may indicate an inadequacy in the role of healthcare providers in raising awareness about prostate cancer, its risk factors, symptoms, and screening tests among the Saudi population. Furthermore, obtaining knowledge from social media has its drawbacks as not all information published on the internet is accurate and sufficient.[5] Age and family history were the most well-known risk factors among our participants, while smoking, alcohol, obesity, fatty diets, and multiple sexual partners were the least known risk factors. This contradicts a study conducted in Nigeria that found that the most familiar risk factor of prostate cancer was sexual activity followed by age, family history, and occupation.[6] However, our results were consistent with the findings of Benurugo et al.[15] (2020), who reported that family history was the most well-known risk factor among participants in Rwanda. Physical activity, fruits and vegetables intake, and low-fat diets were the most well-known protective factors against prostate cancer among our participants. On the other hand, Benurugo et al.[15] (2020) indicated that the participants were not aware of the protective effects of physical activity and diet control. Contrary to the findings of Necku et al.[16] (2019), who reported that almost 76% of participants were aware of the PSA screening test, just under a quarter of our participants (20.3%) had heard about it before from mainly social media (47.1%) and healthcare providers (38.2%). Another study conducted in Italy found that 72.7% of participants were aware of the PSA test from physicians mostly (51.1%).[5] In line with previous studies, more than half of our sample (55.2%) had a poor level of knowledge of both prostate cancer and the PSA test, and 53.1% had a negative attitude towards them.[61617] Only 12.5% of the participants in this study had done a PSA test before, which is lower than what was reported by other studies in Italy, Rwanda, Ghana, and Zambia.[5151617] This may be due to the lack of knowledge and poor attitude among the male population in Saudi Arabia. Therefore, it is essential to raise awareness through campaigns and urge healthcare providers to educate their patients about the risks of prostate cancer and the importance of early screening. Study limitations include the use of a self-administered questionnaire that could lead to response bias in which some participants may give inaccurate responses due to the Hawthorne effect. The questionnaire investigated the participants’ past personal history, which may have resulted in recall bias. Another limitation is the distribution of the questionnaire online, which may be the reason behind the large number of young, educated participants who use social media frequently in our study compared to older participants.

Conclusion

The male population living in Saudi Arabia showed a poor level of knowledge and attitudes toward prostate cancer and early screening. This may be due to an inadequacy in the role of healthcare providers to educate their patients properly about prostate cancer. Further investigations to understand the reasons behind the low level of awareness among the Saudi population are required.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Early detection and aggressive treatment of prostate cancer: groping in the dark.

Authors:  M J Barry
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

Review 2.  Psychological aspects of prostate cancer: a clinical review.

Authors:  A De Sousa; S Sonavane; J Mehta
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-03       Impact factor: 5.554

Review 3.  Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Leen Naji; Harkanwal Randhawa; Zahra Sohani; Brittany Dennis; Deanna Lautenbach; Owen Kavanagh; Monica Bawor; Laura Banfield; Jason Profetto
Journal:  Ann Fam Med       Date:  2018-03       Impact factor: 5.166

Review 4.  American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Authors:  Andrew M D Wolf; Richard C Wender; Ruth B Etzioni; Ian M Thompson; Anthony V D'Amico; Robert J Volk; Durado D Brooks; Chiranjeev Dash; Idris Guessous; Kimberly Andrews; Carol DeSantis; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2010-03-03       Impact factor: 508.702

5.  Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.

Authors:  Paul F Pinsky; Philip C Prorok; Kelly Yu; Barnett S Kramer; Amanda Black; John K Gohagan; E David Crawford; Robert L Grubb; Gerald L Andriole
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

6.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

Review 7.  Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review.

Authors:  Ahmad K Rahal; Robert G Badgett; Richard M Hoffman
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

8.  Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.

Authors:  Marianna Morlando; Concetta Paola Pelullo; Gabriella Di Giuseppe
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.